Cervical cancer screening: on the way to a shift from cytology to full molecular screening. - Wikidata - wikimedia - TriplyDB

Cervical cancer screening: on the way to a shift from cytology to full molecular screening.

Cervical cancer screening: on the way to a shift from cytology to full molecular screening.

http://www.wikidata.org/entity/Q38180277

about

Promoter methylation status of the tumor suppressor genes p16 and cadherin 1 in cervical intraepithelial neoplasia Acceptability and correlates of primary and secondary prevention of cervical cancer among medical students in southwest China: implications for cancer education.Knowledge and attitude of Uyghur women in Xinjiang province of China related to the prevention and early detection of cervical cancer.The end of the decline in cervical cancer mortality in Spain: trends across the period 1981-2012.Systematic review of model-based cervical screening evaluations.Cervical Cancer Prevention: New Frontiers of Diagnostic Strategies An special epithelial staining agents: folic acid receptor-mediated diagnosis (FRD) effectively and conveniently screen patients with cervical cancer Self-sampling in cervical cancer screening: comparison of a brush-based and a lavage-based cervicovaginal self-sampling device.Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand Methylation analysis and HPV genotyping of self-collected cervical samples from women not responding to screening invitation and review of the literature.HPV immunisation and cervical screening--confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study.Triage of HPV positive women in cervical cancer screening.Cytomorphological characteristics of glassy cell carcinoma of the uterine cervix: histopathological correlation and human papillomavirus genotyping.Screening for cervical cancer in French Guiana: screening rates from 2006 to 2011.Inhibiting CD146 by its Monoclonal Antibody AA98 Improves Radiosensitivity of Cervical Cancer Cells.Trop2 gene: a novel target for cervical cancer treatment.Prospective comparison of hybrid capture 2 and SPF₁₀-LiPA for carcinogenic human papillomavirus detection and risk prediction of cervical cancer: a population-based cohort study in China.HPV Testing from Dried Urine Spots as a Tool for Cervical Cancer Screening in Low-Income Countries Low recurrence rate of high-grade cervical intraepithelial neoplasia after successful excision and routine colposcopy during follow-up.Characterization of JAK2 V617F (1849 G > T) Mutation in Cervical Cancer Related to Human Papillomavirus and Sexually Transmitted Infections.New Insights in the Pathogenesis of HPV Infection and the Associated Carcinogenic Processes: The Role of Chronic Inflammation and Oxidative Stress Effectiveness of novel folate receptor-mediated staining solution detection (FRD) for cervical cancer screening

P2860

Q33751094-0B38EA0F-BCAE-4FC5-8D6D-FD64FA701D59 Q34434281-4E1154EA-4D6E-45F4-9A64-1D2965F38E56 Q35211938-AECE6680-895E-4142-A38D-EEEAE08679CD Q35534341-F498C9C0-752C-4281-9CD6-DF9F514B093B Q35568922-7A78D79F-70D1-4035-80BB-7D266BBBBBFC Q35773327-52B77DB7-57C1-46BB-944D-5A9CAD962479 Q35870932-9CC8625B-7AB9-427F-B4EE-52D1827DCBF5 Q35958230-12963010-0605-4E65-9FB5-DC12CC5DCAB0 Q36060165-2FB803E2-1F91-498F-A1E5-53A77B8FA35E Q36298250-5DF4B4A2-5312-470C-9F9C-84E455476FD7 Q36662008-4846067F-9FED-4CB8-9914-BCFFD048B276 Q36679896-CEBD81BA-5B9C-4225-AB79-91B4BA1D47B2 Q37687537-3D9E9CC8-A721-46D3-B928-3A5A7EFED9CB Q38648045-50197A3B-2FDA-4F71-82EA-164A237C2209 Q38744883-7B1B14A2-5772-49CE-8986-A9866049BEF2 Q38996163-5B7091A4-EA97-456E-A905-E1BA0A592717 Q40142951-98AF9C37-9482-473C-9CF0-6C751A3BB8D7 Q40730339-6CB7616F-9D0C-4D10-ACFC-F303C5FD67EE Q49320850-E3F3A71F-0345-4D02-9678-B542BD087B06 Q55711886-E1C7C264-A0E8-4D9D-BFB3-E4B3D4A70816 Q58700402-AE67E4B8-A22B-4410-BA88-2A775C8C0418 Q58706581-1D42AD90-AB9E-44D3-BDFE-037AB02EBE9E

P2860

Cervical cancer screening: on the way to a shift from cytology to full molecular screening.

http://www.wikidata.org/entity/Q38180277

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Cervical cancer screening: on ...... y to full molecular screening.

@en

type

label

Cervical cancer screening: on ...... y to full molecular screening.

@en

prefLabel

Cervical cancer screening: on ...... y to full molecular screening.

@en

P1433

Q38180277-6A9597D0-9E0B-4AEB-9334-1DE73C1E38D9

P1476

Q38180277-60E71F26-CFA8-45C5-88E4-A66A10E29918

P2093

Q38180277-38379606-3E70-4AC8-B754-84AF69260A78

Q38180277-3F15E9B4-22F7-49FD-A31B-28C00E489A50

Q38180277-6156A0C8-0217-40FE-82A9-49ABCB147E44

Q38180277-8EBA2BD0-CE61-4B3F-B13E-52D9737840CD

Q38180277-DA367D7B-D042-4BE2-B411-534A230EABFB

Q38180277-DD9325B3-7D6A-48BA-A9BD-E73FFD96A327

P2860

Q38180277-094B65B2-CCA4-4983-831F-3D0F59919977

Q38180277-09C2A3AC-9C02-4036-959E-2398E1489AFA

Q38180277-0AFEEFC0-4A7A-4A22-A8BE-89E98C9ED5E1

Q38180277-10D8BCFA-77DE-455A-A8DE-BB03B6865793

Q38180277-11143C2A-AFC7-4D51-80B6-66FD343C6877

Q38180277-12EF66C2-510D-45B4-83F9-11D861A27EB3

Q38180277-13C8DBC5-9AD7-4B21-9767-F802650E067B

Q38180277-15E66F0A-2724-4521-8E8E-7065FFD037C5

Q38180277-15F6BBE2-80EC-4972-B479-3481E51264FD

Q38180277-1A5008CB-FAEF-4A20-B33F-F0E5412943AF

P304

Q38180277-D77740B9-5F5B-4D53-9B5F-59C129094DC6

P31

Q38180277-5E78E146-0400-4A83-8DCE-8773D2227208

P356

Q38180277-537767D9-E0BE-4771-9AA2-B7E0401A91B9

P433

Q38180277-EA32FFBC-B147-4D80-998A-45EA13E5A425

P478

Q38180277-D3AEB713-971E-42E6-83ED-9693EA8490E8

P577

Q38180277-6726EFF9-D8FD-4A30-B7B1-C6FCD7F4C277

P5875

Q38180277-57818851-6263-4571-A2E2-2B28A6F09D3F

P698

Q38180277-B9011A2E-3428-4B76-AA14-8D82A911DB93

P356

P1433

Annals of Oncology

P1476

Cervical cancer screening: on ...... y to full molecular screening.

@en

P2093

C J L M Meijer

http://www.w3.org/2001/XMLSchema#string

D C Rijkaart

http://www.w3.org/2001/XMLSchema#string

J Berkhof

http://www.w3.org/2001/XMLSchema#string

M Arbyn

http://www.w3.org/2001/XMLSchema#string

M G Dijkstra

http://www.w3.org/2001/XMLSchema#string

P J F Snijders

http://www.w3.org/2001/XMLSchema#string

P2860

Benefit of cervical screening at different ages: evidence from the UK audit of screening histories

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

Epigenetics in cancer

A review of human carcinogens--Part B: biological agents

Gene silencing in cancer in association with promoter hypermethylation

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study.

POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women.

Comparison of type-specific human papillomavirus data from self and clinician directed sampling.

HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial

P304

927-935

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDT538

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259825584

http://www.w3.org/2001/XMLSchema#string

P698

24445150

http://www.w3.org/2001/XMLSchema#string